Anesthesia-Related Pharmacology and Toxicology

Pharmacodynamics and Cardiopulmonary Side Effects of CW002, a Cysteine-reversible Neuromuscular Blocking Drug in Dogs

Heerdt PM, Malhotra JK, Pan BY, et al (Weill Med College of Cornell Univ, NY) Anesthesiology 112:910-916, 2010^§

Abstract

Background

CW002 is a novel neuromuscular blocking drug with a duration dependent on the rate of cysteine adduction to the molecule. The current study characterized the pharmacodynamics and cardiopulmonary side effects of CW002 in dogs.

Methods

In eight beagles, the dose required to produce 95% neuromuscular blockade (ED₉₅) for CW002 was first determined and cysteine reversibility was confirmed. Five to 7 days later, incrementally larger doses were injected starting with 6.25 × ED₉₅ and doubling the dose every 15 min. Before and after injection, blood was obtained for histamine analysis. Systemic and pulmonary arterial pressures, cardiac output, and left ventricular pressure and volume were recorded along with inspiratory pressure and pulmonary compliance. Ventricular contractility and lusitropy were indexed from pressure and volume data.

Results

The ED₉₅ for CW002 from pooled data was 0.009 mg/kg. At 3 × ED₉₅, onset time was 2.6 ± 0.9 min and duration was 47 ± 9 min. The duration was shortened to 3.7 ± 0.6 min by 50 mg/kg l-cysteine injected 1 min after CW002. At 25 × ED₉₅, CW002 reduced mean arterial pressure with concomitant decreases in systemic vascular resistance, mean pulmonary artery pressure, cardiac output, contractility, and lusitropy, beginning at 50 × ED₉₅. However, even at a dose of 100 × ED₉₅, the average change in any variable was less than 20%. There were no changes in pulmonary vascular resistance or ventilation mechanics at any dose, and histamine release occurred in only two of eight animals.

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study of Cancer: The Next Generation Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A meta-analysis time and haemodynamic response after thiopental vs. propofol in the elderly: a randomized trial use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal Neuromuscular Block: Lessons Unlearned. Part I: Definitions, Incidence, and Adverse Physiologic Effects of Residual Neuromuscular Block